EFFECT OF TIRZEPATIDE VERSUS INSULIN DEGLUDEC ON LIVER FAT CONTENT AND ABDOMINAL ADIPOSE TISSUE IN PATIENTS WITH TYPE 2 DIABETES (SURPASS-3 MRI)

被引：0
|
作者：
Gastaldelli, A. [1 ]
Cusi, K. [2 ]
Lando, L. Fernandez [3 ]
Bray, R. [3 ]
Brouwers, B. [3 ]
Rodriguez, A. [3 ]
机构：
[1] CNR, Inst Clin Physiol, Cardiometab Risk Unit, Pisa, Italy
[2] Univ Florida, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[3] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP030 / #8
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [31] Patients with type 2 diabetes reach glycaemic targets faster with tirzepatide compared to semaglutide and titrated insulin degludec
    Viljoen, A.
    Pantalone, K. M.
    Galindo, R. J.
    Cui, X.
    Huh, R.
    Lando, L. Fernandez
    Patel, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S303 - S303
  • [32] Impaired Insulin-stimulated Fatty Acid Synthesis in Subcutaneous Adipose Tissue Associates with Liver Fat Content in Type 2 Diabetes
    Lundbom, Jesper
    Apostolopoulou, Maria
    Roehling, Martin
    Bierwagen, Alessandra
    Szendroedi, Julia
    Roden, Michael
    DIABETES, 2016, 65 : A466 - A466
  • [33] The ratio of deep to whole subcutaneous adipose tissue thickness is higher in type 2 diabetes and relates to insulin resistance and liver fat content
    Bodis, K.
    Lundbom, J.
    Jelenik, T.
    Markgraf, D.
    Burkart, V.
    Muessig, K.
    Szendroedi, J.
    Roden, M.
    DIABETOLOGIA, 2016, 59 : S315 - S315
  • [34] Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content
    Lindroos, Markus M.
    Borra, Ronald
    Mononen, Nina
    Lehtimaki, Terho
    Virtanen, Kirsi A.
    Lepomaki, Virva
    Guiducci, Letizia
    Iozzo, Patricia
    Majamaa, Kari
    Nuutila, Pirjo
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (06) : 1205 - 1212
  • [35] Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 760 - 766
  • [36] Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
    Juurinen, Leena
    Tiikkainen, Mirja
    Hakkinen, Anna-Maija
    Hakkarainen, Antti
    Yki-Jarvinen, Hannele
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E829 - E835
  • [37] Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
    Juurinen, L
    Tiikkainen, M
    Häkkinen, AM
    Järvinen, H
    DIABETOLOGIA, 2005, 48 : A59 - A59
  • [38] The Relationship Between Brown Adipose Tissue Content in Supraclavicular Fat Depots and Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus and Prediabetes
    Koksharova, Ekaterina
    Ustyuzhanin, Dmitry
    Philippov, Yury
    Mayorov, Alexander
    Shestakova, Marina
    Shariya, Merab
    Ternovoy, Sergey
    Dedov, Ivan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (02) : 96 - 102
  • [39] Effects of tirzepatide versus insulin glargine 100 U/mL on kidney outcomes in participants with type 2 diabetes in SURPASS-4
    Heerspink, H. J. L.
    Sattar, N.
    Pavo, I.
    Haupt, A.
    Duffin, K. L.
    Yang, Z.
    Wiese, R. J.
    Tuttle, K. R.
    Cherney, D. Z. I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S316 - S316
  • [40] Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD
    Kalavalapalli, Srilaxmi
    Leiva, Eddison Godinez
    Lomonaco, Romina
    Chi, Xiaofei
    Shrestha, Sulav
    Dillard, Rachel
    Budd, Jeffery
    Romero, Jessica Portillo
    Li, Christina
    Bril, Fernando
    Samraj, George
    Pennington, John
    Townsend, Petra
    Orlando, Frank
    Shetty, Shwetha
    Mansour, Lydia
    Silva-Sombra, Lorena Rodrigues
    Bedossa, Pierre
    Malaty, John
    Barb, Diana
    Gurka, Matthew J.
    Cusi, Kenneth
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (05): : 1192 - 1201
12345